Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 123 points (-0.7%) at 17,854 as of Tuesday, March 17, 2015, 1:00 PM ET. The NYSE advances/declines ratio sits at 1,105 issues advancing vs. 1,894 declining with 134 unchanged.

The Real Estate industry currently sits down 0.1% versus the S&P 500, which is down 0.4%. A company within the industry that increased today was BBX Capital ( BBX), up 36.1%. On the negative front, top decliners within the industry include Macerich ( MAC), down 2.9%, Realogy Holdings ( RLGY), down 2.0%, Icahn ( IEP), down 0.9% and Plum Creek Timber ( PCL), down 0.8%.

TheStreet would like to highlight 3 stocks pushing the industry higher today:

3. BioMed Realty ( BMR) is one of the companies pushing the Real Estate industry higher today. As of noon trading, BioMed Realty is up $0.20 (0.9%) to $21.98 on average volume. Thus far, 835,758 shares of BioMed Realty exchanged hands as compared to its average daily volume of 2.1 million shares. The stock has ranged in price between $21.68-$22.01 after having opened the day at $21.78 as compared to the previous trading day's close of $21.78.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

BioMed Realty Trust, Inc. operates as a real estate investment trust (REIT) that focuses on providing real estate to the life science industry in the United States. BioMed Realty has a market cap of $4.4 billion and is part of the financial sector. Shares are up 1.1% year-to-date as of the close of trading on Monday. Currently there are 6 analysts who rate BioMed Realty a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates BioMed Realty as a buy. The company's strengths can be seen in multiple areas, such as its increase in stock price during the past year, compelling growth in net income, revenue growth, reasonable valuation levels and impressive record of earnings per share growth. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full BioMed Realty Ratings Report now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

2. As of noon trading, Ocwen Financial ( OCN) is up $0.33 (3.8%) to $8.97 on light volume. Thus far, 1.9 million shares of Ocwen Financial exchanged hands as compared to its average daily volume of 9.3 million shares. The stock has ranged in price between $8.49-$8.98 after having opened the day at $8.57 as compared to the previous trading day's close of $8.64.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Ocwen Financial Corporation, through its subsidiaries, is engaged in the servicing and origination of mortgage loans in the United States and internationally. Ocwen Financial has a market cap of $1.2 billion and is part of the financial sector. Shares are down 42.8% year-to-date as of the close of trading on Monday. Currently there is 1 analyst who rates Ocwen Financial a buy, 1 analyst rates it a sell, and 4 rate it a hold.

TheStreet Ratings rates Ocwen Financial as a hold. The company's strengths can be seen in multiple areas, such as its reasonable valuation levels, good cash flow from operations and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself, deteriorating net income and disappointing return on equity. Get the full Ocwen Financial Ratings Report now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

1. As of noon trading, HCP ( HCP) is up $0.26 (0.6%) to $40.82 on light volume. Thus far, 992,376 shares of HCP exchanged hands as compared to its average daily volume of 3.7 million shares. The stock has ranged in price between $40.28-$41.04 after having opened the day at $40.56 as compared to the previous trading day's close of $40.56.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

HCP, Inc. is an independent hybrid real estate investment trust. The fund invests in real estate markets of the United States. HCP has a market cap of $18.5 billion and is part of the financial sector. Shares are down 7.9% year-to-date as of the close of trading on Monday. Currently there are 2 analysts who rate HCP a buy, 2 analysts rate it a sell, and 9 rate it a hold.

TheStreet Ratings rates HCP as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations, increase in stock price during the past year and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full HCP Ratings Report now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the real estate industry could consider iShares Dow Jones US Real Estate ( IYR) while those bearish on the real estate industry could consider ProShares Short Real Estate Fund ( REK).

null